These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26050016)

  • 21. KIR and HLA interactions are associated with control of primary CMV infection in solid organ transplant recipients.
    van Duin D; Avery RK; Hemachandra S; Yen-Lieberman B; Zhang A; Jain A; Butler RS; Barnard J; Schold JD; Fung J; Askar M
    Am J Transplant; 2014 Jan; 14(1):156-62. PubMed ID: 24369024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
    Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.
    Littera R; Orrù N; Vacca A; Bertaina A; Caocci G; Mulargia M; Giardini C; Piras E; Mastronuzzi A; Vinti L; Orrù S; Locatelli F; Carcassi C; La Nasa G
    Bone Marrow Transplant; 2010 Nov; 45(11):1618-24. PubMed ID: 20173792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.
    Merindol N; Salem Fourati I; Brito RM; Grenier AJ; Charrier E; Cordeiro P; Caty M; Mezziani S; Malette B; Duval M; Alfieri C; Ovetchkine P; Le Deist F; Soudeyns H
    J Immunol; 2012 Nov; 189(10):5016-28. PubMed ID: 23034171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection.
    Di Bona D; Scafidi V; Plaia A; Colomba C; Nuzzo D; Occhino C; Tuttolomondo A; Giammanco G; De Grazia S; Montalto G; Duro G; Cippitelli M; Caruso C
    J Infect Dis; 2014 Oct; 210(7):1083-9. PubMed ID: 24737799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients.
    Bai X; Rogers BB; Harkins PC; Sommerauer J; Squires R; Rotondo K; Quan A; Dawson DB; Scheuermann RH
    J Mol Diagn; 2000 Nov; 2(4):191-201. PubMed ID: 11232109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
    Sauerbrei A; Wutzler P
    J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders.
    Chen C; Busson M; Rocha V; Appert ML; Lepage V; Dulphy N; Haas P; Socié G; Toubert A; Charron D; Loiseau P
    Bone Marrow Transplant; 2006 Sep; 38(6):437-44. PubMed ID: 16892071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
    Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.
    Kröger N; Binder T; Zabelina T; Wolschke C; Schieder H; Renges H; Ayuk F; Dahlke J; Eiermann T; Zander A
    Transplantation; 2006 Oct; 82(8):1024-30. PubMed ID: 17060849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
    Ogunjimi B; Theeten H; Hens N; Beutels P
    J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.
    Kronenberg A; Bossart W; Wuthrich RP; Cao C; Lautenschlager S; Wiegand ND; Mullhaupt B; Noll G; Mueller NJ; Speck RF
    Transpl Infect Dis; 2005; 7(3-4):116-21. PubMed ID: 16390399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients.
    Farzamikia N; Hejazian SM; Haghi M; Hejazian SS; Zununi Vahed S; Ardalan M
    Immunogenetics; 2022 Apr; 74(2):207-212. PubMed ID: 35091752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
    Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast patterns of Cytomegalovirus and Epstein-Barr virus infection in pediatric living-donor liver transplant recipients.
    Nafady-Hego H; Elgendy H; Uemoto S
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():75-82. PubMed ID: 25894132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on KIR gene polymorphisms in 416 renal transplantation recipients from southern Zhejiang].
    Chen XQ; Wu Q; Xie SS; Zhao WJ; Wu CZ; Cai Y; Xia P; Yang YR; Chen BC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):701-5. PubMed ID: 24327151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.
    Carratalà J; Montejo M; Pérez-Romero P
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():63-9. PubMed ID: 22542037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.
    Yabe T; Matsuo K; Hirayasu K; Kashiwase K; Kawamura-Ishii S; Tanaka H; Ogawa A; Takanashi M; Satake M; Nakajima K; Tokunaga K; Inoko H; Saji H; Ogawa S; Juji T; Sasazuki T; Kodera Y; Morishima Y;
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):75-87. PubMed ID: 18158964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.